Can (18)F-PSMA-7Q PET/CT replace prostate biopsy for the diagnosis of prostate cancer?—A single-center retrospective study

BACKGROUND: Of the currently available prostate-specific membrane antigen (PSMA) positron emission tomography (PET) tracers, although (68)Ga-PSMA-11 and (18)F-DCFPyL have been approved by the US Food and Drug Administration (FDA), both tracers are excreted rapidly through the urinary tract, resultin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yachao, Niu, Shaoxi, Luan, Xiaohui, Zhang, Xiaojun, Liu, Jiajin, Zhang, Jinming, Wang, Ruimin, Xu, Baixuan, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906103/
https://www.ncbi.nlm.nih.gov/pubmed/36760865
http://dx.doi.org/10.21037/tau-22-813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906103/
https://www.ncbi.nlm.nih.gov/pubmed/36760865
http://dx.doi.org/10.21037/tau-22-813

Ejemplares similares